Let's connect

Day: February 6, 2023

Novalis Biotech invests in Rarity Bioscience’s
ultra sensitive genomics technology

Wim Van Criekinge, Co-Founder and Managing Director at Novalis_Linus Bosaeus, CEO at Rarity Bioscience

To further accelerate growth, Rarity Bioscience announces today a new strategicinvestment from Belgium based Novalis Biotech. The investment is facilitated as anoversubscription of the recent round closed in November 2022. Apart from previousowner, that round also included Wallenberg Investments through Navigare Venture,now bringing the total investment round to €3M. Novalis Biotech (Ghent, Belgium) is an […]

Gain access to our content!

Provide your email to get access to this, and all our other documents!

Thank you for submitting the form!

Download the document here

Now you can download any document on our website! 

Rarity Bioscience
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.